GAD THOMAS (President and Chairman) sold 58.4% of their position (95K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.26M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/17/2024ACC: 0001415889-24-023554
DirectorOfficer· President and Chairman
Since Sep 2018
-95K
Net shares
Net seller
$1.26M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
95K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−65K
Price / share
$13.47
Trade value
$875.55K
% of position
40.0%
9/13/2024
162.68K→97.68K
Common Stock
Indirect
Shares
−30K
Price / share
$12.97
Trade value
$389.10K
% of position
30.7%
9/16/2024
97.68K→67.68K
Total
Net shares
−95K
Net value
-$1.26M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/13/2024 | S · Sale | −65K | $13.47 | $875.55K | 40.0% | 162.68K | 97.68K |
| Common Stock Indirect | 9/16/2024 | S · Sale | −30K | $12.97 | $389.10K | 30.7% | 97.68K | 67.68K |
| Total | −95K | -$1.26M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned158.70K
Common Stock
IndirectShares owned60K
Total
158.70K direct·60K indirect218.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 158.70K | Direct |
| Common Stock | 60K | Indirect |
| Total | 218.70K | 158.70K direct·60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported